Skip to content
★ Sign in to follow
Ceryvyn Therapeutics Limited logo

Ceryvyn Therapeutics Limited Stock: price and insider trades · Australia

ISIN AU0000478117AU·Mcap A$15MHealth Care

Ceryvyn Therapeutics Limited: what insiders have been doing

Every trade that managers of Ceryvyn Therapeutics Limited disclose to ASX is tracked on this page. The company sits in the Health Care sector. 1 insider has disclosed 4 filings since 23 October 2025.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Insider buying of Ceryvyn Therapeutics Limited has been absent for the past year.

With 4 filings in twelve months, the company is in line with the median of 4 filings across the 1,594 companies we follow on the same exchange.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.

Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

as of FY 2026

FY ended June 2026 · cache

A$0.01
Analyst consensus
1 analysts
·
A$0.10Target A$0.10(+809%)A$0.10
Income statement
RevenueA$1k
Gross profit-A$88.3k-8826% margin
EBITDAA$341.3M34129500% margin
Net incomeA$330.4M33044500.0% margin
Valuation
PER (trailing)0.0x
P/Book0.5x
Beta1.48
Balance sheet & cash
Market capA$15M
Free Cash Flow-A$12.5M
Profitability & ownership
ROA-12.6%
% insiders35.4%
% institutions4.3%
Last declaration on 13 October 2026
Declarations4 total
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    Executives
    Executives(filed)
    0ASX

4 of 4 declarations

About Ceryvyn Therapeutics Limited

CYV is a company listed on the XASX market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations